Real-World Effectiveness and Safety of Ustekinumab Use in Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
Am. J. Gastroenterol 2023 Feb 01;118(2)317-328, AM Johnson, M Barsky, W Ahmed, S Zullow, J Galati, V Jairath, N Narula, F Peerani, BH Click, ES Coburn, TT Dang, S Gold, M Agrawal, R Garg, M Aggarwal, D Mohammad, B Halloran, GS Kochhar, H Todorowski, NM Ud Din, J Izanec, A Teeple, C Gasink, E Muser, Z Ding, A Swaminath, K Lakhani, D Hogan, S Datta, RC Ungaro, BS Boland, M Bohm, M Fischer, S Sagi, A Afzali, T Ullman, G Lawlor, DC Baumgart, S Chang, D Hudesman, D Lukin, EJ Scherl, JF Colombel, BE Sands, CA Siegel, M Regueiro, WJ Sandborn, D Bruining, S Kane, EV Loftus, PS DulaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.